Although multiple studies have indicated that certain genetic alterations drive the highly invasive and drug-resistant phenotypes of SCLC, including MYC, SLFN11, PTEN, and Notch/Sting pathways, genomic analysis of SCLC patients has yet to reveal a subtype defined by specific genetic changes [36–41]. This evidence concerns the gene PTEN and small cell lung carcinoma.